EdiGene raises around $10M in pre-B+ round

Gene editing company EdiGene Inc. (Beijing, China) closed a pre-B+ round of financing to raise about RMB70 million ($10.3 million).

In August, EdiGene raised about $15 million in a pre-B round (see "Lilly Asia Ventures leads $15M EdiGene round")...